Connection

Dominic Dwyer to Humans

This is a "connection" page, showing publications Dominic Dwyer has written about Humans.
Connection Strength

0.088
  1. Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low. Pathology. 2020 12; 52(7):809-811.
    View in: PubMed
    Score: 0.007
  2. Point-of-care diagnostics for respiratory viral infections. Expert Rev Mol Diagn. 2018 01; 18(1):75-83.
    View in: PubMed
    Score: 0.006
  3. Zika virus: what, where from and where to? Pathology. 2017 Dec; 49(7):698-706.
    View in: PubMed
    Score: 0.006
  4. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev Med. 2014 May; 62:1-7.
    View in: PubMed
    Score: 0.005
  5. Truth, double truth and statistics. N S W Public Health Bull. 2010 Jan-Feb; 21(1-2):30-1.
    View in: PubMed
    Score: 0.003
  6. Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). Virol J. 2007 Mar 27; 4:32.
    View in: PubMed
    Score: 0.003
  7. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis. 2005 Nov; 9(6):323-30.
    View in: PubMed
    Score: 0.003
  8. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clin Diagn Lab Immunol. 2004 Jul; 11(4):792-4.
    View in: PubMed
    Score: 0.002
  9. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology. 2003 Dec; 35(6):526-31.
    View in: PubMed
    Score: 0.002
  10. Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019. Clin Infect Dis. 2021 11 02; 73(9):e2952-e2959.
    View in: PubMed
    Score: 0.002
  11. Origins of SARS-CoV-2: window is closing for key scientific studies. Nature. 2021 08; 596(7873):482-485.
    View in: PubMed
    Score: 0.002
  12. Broadsheet: Clinical and laboratory features of rubella. Pathology. 2001 Aug; 33(3):322-8.
    View in: PubMed
    Score: 0.002
  13. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. PLoS Med. 2021 07; 18(7):e1003656.
    View in: PubMed
    Score: 0.002
  14. Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic. J Med Virol. 2021 Jul; 93(7):4099-4101.
    View in: PubMed
    Score: 0.002
  15. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Med J Aust. 2021 03; 214(4):179-185.
    View in: PubMed
    Score: 0.002
  16. COVID-19 in Australia: our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phase. Intern Med J. 2021 01; 51(1):42-51.
    View in: PubMed
    Score: 0.002
  17. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam. PLoS One. 2020; 15(11):e0242537.
    View in: PubMed
    Score: 0.002
  18. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020 11; 25(47).
    View in: PubMed
    Score: 0.002
  19. Clinical evaluation of SARS-CoV-2 point-of-care antibody tests. Pathology. 2020 Dec; 52(7):783-789.
    View in: PubMed
    Score: 0.002
  20. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling. Nat Med. 2020 09; 26(9):1398-1404.
    View in: PubMed
    Score: 0.002
  21. Human coronavirus data from four clinical trials of masks and respirators. Int J Infect Dis. 2020 Jul; 96:631-633.
    View in: PubMed
    Score: 0.002
  22. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus. J Clin Virol. 2020 06; 127:104374.
    View in: PubMed
    Score: 0.002
  23. Comparison of three commercial assays for the quantification of plasma HIV-1 RNA from individuals with low viral loads. AIDS. 1999 Oct 01; 13(14):1977-8.
    View in: PubMed
    Score: 0.002
  24. Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015. J Infect. 2019 10; 79(4):373-382.
    View in: PubMed
    Score: 0.002
  25. An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines. Vaccine. 2019 07 18; 37(31):4246-4255.
    View in: PubMed
    Score: 0.002
  26. Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia. Viruses. 2019 05 27; 11(5).
    View in: PubMed
    Score: 0.002
  27. Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia. Viruses. 2018 09 06; 10(9).
    View in: PubMed
    Score: 0.002
  28. Simultaneous co-detection of wild-type and vaccine strain measles virus using the BD MAX system. Pathology. 2018 Jun; 50(4):450-454.
    View in: PubMed
    Score: 0.002
  29. Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine. 2018 05 11; 36(20):2794-2798.
    View in: PubMed
    Score: 0.002
  30. Emerging recombinant noroviruses identified by clinical and waste water screening. Emerg Microbes Infect. 2018 Mar 29; 7(1):50.
    View in: PubMed
    Score: 0.002
  31. The impact of influenza virus infection in pregnancy. Future Microbiol. 2018 02; 13:263-274.
    View in: PubMed
    Score: 0.002
  32. Declining measles antibodies in the era of elimination: Australia's experience. Vaccine. 2018 01 25; 36(4):507-513.
    View in: PubMed
    Score: 0.001
  33. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2016: the Influenza Complications Alert Network (FluCAN). Commun Dis Intell Q Rep. 2017 Dec 01; 41(4):E337-E347.
    View in: PubMed
    Score: 0.001
  34. Multiple Sources of Genetic Diversity of Influenza A Viruses during the Hajj. J Virol. 2017 06 01; 91(11).
    View in: PubMed
    Score: 0.001
  35. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network. Commun Dis Intell Q Rep. 2016 Dec 24; 40(4):E521-E526.
    View in: PubMed
    Score: 0.001
  36. What assay is optimal for the diagnosis of measles virus infection? An evaluation of the performance of a measles virus real-time reverse transcriptase PCR using the Cepheid SmartCycler(®) and antigen detection by immunofluorescence. J Clin Virol. 2015 Sep; 70:46-52.
    View in: PubMed
    Score: 0.001
  37. Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin. 2014 Dec; 29(6):364-71.
    View in: PubMed
    Score: 0.001
  38. A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims. J Epidemiol Glob Health. 2015 Jun; 5(2):181-9.
    View in: PubMed
    Score: 0.001
  39. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 2010 Jul; 87(1):16-21.
    View in: PubMed
    Score: 0.001
  40. The "Grim Reaper" campaign. Med J Aust. 1988 Jul 04; 149(1):49-50.
    View in: PubMed
    Score: 0.001
  41. Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. J Clin Microbiol. 2005 May; 43(5):2339-44.
    View in: PubMed
    Score: 0.001
  42. Identification of infection of an Australian resident with the human immunodeficiency virus type 2 (HIV-2). Med J Aust. 1992 Sep 21; 157(6):415-7.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.